Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.

about

Predictive value of different proportion of lesion HLA-G expression in colorectal cancer.Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges

P2860

Q47139094-DE6D9A54-F22A-47A5-9EB2-1F41B65C6182 Q57490851-9AC62531-2757-4992-913F-3C205AEE40B4

P2860

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.

Item

http://www.wikidata.org/entity/Q53064214

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Intratumor heterogeneity of im ...... cer: Focus on HLA-G/ILT2/ILT4.

@en

Intratumor heterogeneity of im ...... cer: Focus on HLA-G/ILT2/ILT4.

@nl

type

Item

label

Intratumor heterogeneity of im ...... cer: Focus on HLA-G/ILT2/ILT4.

@en

Intratumor heterogeneity of im ...... cer: Focus on HLA-G/ILT2/ILT4.

@nl

prefLabel

Intratumor heterogeneity of im ...... cer: Focus on HLA-G/ILT2/ILT4.

@en

Intratumor heterogeneity of im ...... cer: Focus on HLA-G/ILT2/ILT4.

@nl

P1476

Intratumor heterogeneity of im ...... ncer: Focus on HLA-G/ILT2/ILT4

@en

P2093

Christophe Hennequin

http://www.w3.org/2001/XMLSchema#string

Diana Tronik-Le Roux

http://www.w3.org/2001/XMLSchema#string

Edgardo D Carosella

http://www.w3.org/2001/XMLSchema#string

François Desgrandchamps

http://www.w3.org/2001/XMLSchema#string

Jérôme Verine

http://www.w3.org/2001/XMLSchema#string

Nathalie Rouas-Freiss

http://www.w3.org/2001/XMLSchema#string

Stéphane Culine

http://www.w3.org/2001/XMLSchema#string

P2860

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases

Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules

Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Inhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10.

HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

P304

e1342023

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2017.1342023

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joel LeMaoult

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28932645

http://www.w3.org/2001/XMLSchema#string

P932

5599087

http://www.w3.org/2001/XMLSchema#string

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.

about

P2860

P2860

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932